Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer
Clinical trial NCT00633464 · COMPLETED
Trial details
- NCT number
- NCT00633464
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2010-09-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.